Patent details

Basic Information

Publication number:

EP3640251

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP191890102

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

6,7,8,9-TETRAHYDRO-3H-PYRAZOLO[4,3-F]ISOQUINOLINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER

French Title of Invention:

DÉRIVÉS DE 6,7,8,9-TÉTRAHYDRO-3H-PYRAZOLO[4,3-F]ISOQUINOLÉINE UTILES DANS LE TRAITEMENT DU CANCER

German Title of Invention:

6,7,8,9-TETRAHYDRO-3H-PYRAZOLO[4,3-F]ISOCHINOLINDERIVATE ZUR BEHANDLUNG VON KREBS

SPC Number:

Dates

Filing date:

13/10/2017

Grant date:

08/12/2021

EP Publication Date:

22/04/2020

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/12/2021

EP B1 Publication Date:

08/12/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

13/10/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/12/2021

 

 

Name:

Astrazeneca AB

Address:

Forskargatan 18, 151 85 Södertälje, Sweden (SE)

Agent

Name:

ARONOVA S.A.

From:

23/02/2022

Address:

PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)

To:

Inventor

1

Name:

YANG, Bin

Address:

United States (US)

2

Name:

HUGHES, Samantha Jayne

Address:

United Kingdom (GB)

3

Name:

BARLAAM, Bernard Christophe

Address:

United Kingdom (GB)

4

Name:

SCOTT, James Stewart

Address:

United Kingdom (GB)

5

Name:

NISSINK, Johannes Wilhelmus Maria

Address:

United Kingdom (GB)

6

Name:

MOSS, Thomas Andrew

Address:

United Kingdom (GB)

7

Name:

O'DONOVAN, Daniel Hillebrand

Address:

United Kingdom (GB)

Priority

1

Priority Number:

201662411799 P

Priority Date:

24/10/2016

Priority Country:

United States (US)

2

Priority Number:

201662435159 P

Priority Date:

16/12/2016

Priority Country:

United States (US)

Classification

IPC classification:

C07D 471/04; A61K 31/4738; A61K 31/497; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202149

Publication date:

08/12/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

02/11/2026

Annual Fee Number:

10

Annual Fee Amount:

131 Euro

Expected Payer:

Last Annual Fee Payment Date:

23/09/2025

Last Annual Fee Paid Number:

9

Last Annual Fee Paid Amount:

115 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
23/02/2022	Power Of Attorney	1
23/02/2022	Outgoing Correspondence	1